From August 1, 2022 to September 30, 2022, the company has repurchased 274,400 shares, representing 0.73% for ¥933.83 million. With this, the company has completed the repurchase of 274,400 shares, representing 0.73% for ¥933.83 million under the buyback announced on August 1, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,995 JPY | -0.33% | -1.96% | -8.41% |
Apr. 25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
Mar. 21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.41% | 683M | |
+37.78% | 723B | |
+31.11% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.53% | 244B | |
-4.50% | 208B | |
+10.00% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 1, 2022.